Detalles de la búsqueda
1.
PSMA ADC monotherapy in patients with progressive metastatic castration-resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open-label single-arm phase 2 study.
Prostate
; 80(1): 99-108, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31742767
2.
Phase 1 study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific membrane antigen, in chemotherapy-refractory prostate cancer.
Prostate
; 79(6): 604-613, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30663074
3.
First-in-human study of TK-positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cells.
J Transl Med
; 17(1): 271, 2019 08 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31426803
4.
Limited genomic heterogeneity of circulating melanoma cells in advanced stage patients.
Phys Biol
; 12(1): 016008, 2015 Jan 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25574741
5.
An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma.
CNS Oncol
; 12(3): CNS102, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37462385
6.
Bintrafusp alfa, a bifunctional fusion protein targeting TGF-ß and PD-L1, in advanced squamous cell carcinoma of the head and neck: results from a phase I cohort.
J Immunother Cancer
; 8(2)2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32641320
7.
Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study.
J Immunother Cancer
; 8(2)2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32907924
8.
Bintrafusp alfa, a bifunctional fusion protein targeting TGF-ß and PD-L1, in patients with human papillomavirus-associated malignancies.
J Immunother Cancer
; 8(2)2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33323462
9.
Patient-specific dendritic cell vaccines with autologous tumor antigens in 72 patients with metastatic melanoma.
Melanoma Manag
; 6(2): MMT20, 2019 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-31406564
10.
An early feasibility study of the Nativis Voyager® device in patients with recurrent glioblastoma: first cohort in US.
CNS Oncol
; 8(1): CNS30, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30547676
11.
Interruptions of once-daily thoracic radiotherapy do not correlate with outcomes in limited stage small cell lung cancer: analysis of CALGB phase III trial 9235.
Lung Cancer
; 62(1): 92-8, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18367288
12.
Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses.
J Immunother Cancer
; 6(1): 19, 2018 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29510745
13.
Phase I/II study of IV topotecan in combination with whole brain radiation for the treatment of brain metastases.
Med Oncol
; 24(2): 147-53, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17848737
14.
Phase I single dose, two-period and two-sequence cross-over trial to evaluate the relative bioavailability of two oral pimasertib formulations in advanced cancer patients.
Cancer Chemother Pharmacol
; 79(4): 681-688, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28289865
15.
Dendritic Versus Tumor Cell Presentation of Autologous Tumor Antigens for Active Specific Immunotherapy in Metastatic Melanoma: Impact on Long-Term Survival by Extent of Disease at the Time of Treatment.
Cancer Biother Radiopharm
; 30(5): 187-94, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26083950
16.
Adjuvant therapy for patients with high-risk malignant melanoma.
Semin Oncol
; 29(4): 389-99, 2002 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-12170442
17.
Systemic chemotherapy for the treatment of metastatic melanoma.
Semin Oncol
; 29(5): 413-26, 2002 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-12407507
18.
Completely regressed cutaneous melanocytic lesion: was it benign or was it malignant?
Semin Oncol
; 36(5): 375-9, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19835734
19.
Phase I/II trial of melanoma patient-specific vaccine of proliferating autologous tumor cells, dendritic cells, and GM-CSF: planned interim analysis.
Cancer Biother Radiopharm
; 19(5): 658-65, 2004 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-15650459
20.
Tumor stem cell antigens as consolidative active specific immunotherapy: a randomized phase II trial of dendritic cells versus tumor cells in patients with metastatic melanoma.
J Immunother
; 35(8): 641-9, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22996370